ABOPM Seal
Donate Today Log In
Research & Discovery

Evidence-Driven
Research at Scale

Literature Review · Clinical Trials · Biomarker Discovery · Data Analysis · Peer Review · Translational Science

500+

Studies Published

40+

Active Trials

IRB

Approved Protocol

100%

Open Access

Re·search

The systematic investigation into and study of materials, sources, and clinical phenomena in order to establish facts, validate hypotheses, and advance the standards of precision medicine.

Focus Areas

Biomarker discovery, translational science, clinical trial design, real-world evidence, and outcomes research, all anchored in IRB-approved, peer-reviewed standards of inquiry.

The Research at the American Board of Precision Medicine drives the evidence base that underpins clinical certification generating and synthesizing knowledge across multi-omics, therapeutics, and population health to inform standards that physicians can trust.

From biomarker discovery and translational studies to large-scale clinical trials and real-world outcomes analysis, this department connects bench science to boardroom policy ensuring every standard ABOPM sets is grounded in rigorous, reproducible evidence.

Research at ABOPM is not peripheral - it is the engine of credibility that keeps precision medicine standards current, defensible, and clinically meaningful.

500+

Studies Published

40+

Active Trials

IRB

Approved Protocol

Research Department · ABOPM

Where Evidence Meets
Clinical Certainty

The Research at ABOPM exists at the intersection of scientific inquiry and clinical practice generating the rigorous, reproducible evidence that drives certification standards, informs physician training, and advances the field of precision medicine.

Biomarker Discovery

Identifying and validating biological markers that predict disease onset, progression, and therapeutic response building the molecular evidence base for precision diagnostics and targeted treatment.

Clinical Trials

Designing and overseeing IRB-approved studies that test precision medicine interventions at scale from early-phase translational research to real-world outcomes analysis across diverse patient populations.

Translational Science

Accelerating the journey from bench discovery to bedside application synthesizing multi-omics data, population studies, and clinical evidence into actionable standards physicians can apply today.

"Research is not what happens before medicine - it is the engine that keeps medicine honest, current, and worthy of patient trust. At ABOPM, every standard we set begins with evidence."

American Board of Precision Medicine · Research Department
Genomics Department · ABOPM

Shaping the Future
of Precision Medicine

As precision medicine continues to evolve, genomics will play an increasingly central role in redefining how disease is understood, predicted, and treated at the molecular level.

The Genomics Department at ABOPM remains committed to advancing this field through scientific leadership, clinical innovation, and collaborative discovery. Together with our global community of physicians and researchers, we are helping shape the future of next-generation healthcare.

Featured Insights

Insights Shaping
Precision Medicine

Explore ABOPM perspectives on genomics, multi-omics, systems thinking, clinical innovation, and the future of physician leadership in precision medicine.

Multi-Omics Clinical Innovation Precision Prevention Physician Leadership
Multiple Sclerosis and the Microbiome: What Emerging Research Is Teaching Us About Precision Medicine

Multiple Sclerosis and the Microbiome: What Emerging Research Is Teaching Us About Precision Medicine

Emerging research is uncovering connections between multiple sclerosis, the gut microbiome, genetics, and immune function. Explore what these findings could mean for the future of precision medicine. ...more

Population Precision

September 24, 2026•11 min read

Global Genomics Initiatives Expanding Precision Medicine

Global Genomics Initiatives Expanding Precision Medicine

Discover how global genomics initiatives are expanding precision medicine through diverse population data, large-scale sequencing, disease risk prediction, rare disease research, and advances in perso... ...more

Population Precision

September 17, 2026•8 min read

Liquid Biopsy 2.0: Beyond Cancer Detection

Liquid Biopsy 2.0: Beyond Cancer Detection

Liquid Biopsy 2.0 is moving beyond cancer. Discover how circulating biomarkers, cell-free DNA, RNA, and extracellular vesicles could transform disease detection, monitoring, and the future of precisio... ...more

On the Frontier

September 10, 2026•8 min read

Advancing education, certification, and leadership to shape a genomics-driven, data-intelligent future of healthcare.

2810 N Church St., PMB 364141
Wilmington, Delaware 19802-4447 US

+1 (954) 944-2717


© 2023-2025 American Board of Precision Medicine, Inc. All Rights Reserved.